The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Congo, Democratic Republic of the currently stands at 37%, indicating a decrease of 4% (-9.8%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Congo, Democratic Republic of the
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Congo, Democratic Republic of the
PMTCT antiretroviral therapy coverage
More indicators for Congo, Democratic Republic of the
Male unintentional poisoning
2.9
-0.2
(2019)
Female wasting in children
5.8%
-1.1%
(2017)
Female prevalence of HIV
0.2%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar18
+intl dollar0
(2021)
Birth registration
40.1%
+15.5%
(2018)
Contraceptive modern method prevalence
17.6%
+9.8%
(2018)
Congo, Democratic Republic of the PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 37% | -4% |
| 2021 | 41% | -4% |
| 2020 | 45% | -7% |
| 2019 | 52% | +12% |
| 2018 | 40% | -9% |
| 2017 | 49% | -5% |
| 2016 | 54% | +16% |
| 2015 | 38% | +28% |
| 2014 | 10% | +7% |
| 2013 | 3% | +3% |
| 2012 | 0% | -3% |
| 2011 | 3% | +3% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |